ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

58
Analysis
Health Care • New Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
bullish•Pacific Edge
•01 Dec 2022 08:01•Broker

Pacific Edge (PEB): 1H23 Result – Initial Impressions

Pacific Edge (PEB) reported a 1H23 reported revenue result ahead of our expectations with revenue of NZ$13.6m versus our NZ$9.4m driven by strong...

Logo
388 Views
Share
bullish•Pacific Edge
•24 Oct 2022 06:23•Broker

Pacific Edge (PEB): 2Q23 Update – Solid Momentum Continues

Pacific Edge’s (PEB) 2Q23 test volumes highlight ongoing solid momentum with +11% sequential growth versus 1Q23 and +36% year on year

Logo
261 Views
Share
bullish•Pacific Edge
•17 Aug 2022 12:39•Broker

Pacific Edge: Balanced On a Knife's Edge

PEB confirmed notification of the inclusion of Cxbladder CPT codes in a draft proposal for a different approach to determine which cancer biomarker...

Logo
310 Views
Share
bullish•Pacific Edge
•27 Jul 2022 08:03•Broker

Pacific Edge (PEB): 1Q23 Update

Pacific Edge (PEB)   1Q23 Update Pacific Edge (PEB) has this morning provided a detailed investor update, including 1Q23 lab throughput numbers....

Logo
513 Views
Share
bullish•Pacific Edge
•03 Jun 2022 08:06•Broker

Pacific Edge: FY22 Result — Patiently Waiting

Pacific EdgeFY22 Result — Patiently Waiting OUTPERFORM Pacific Edge's (PEB) FY22 result highlighted a continuation of recent trends through 2H22...

Logo
826 Views
Share
x